Epidemiology of invasive fungal disease in lymphoproliferative disorders.

Item

http://www.wikidata.org/entity/Q42910837

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Epidemiology of invasive fungal disease in lymphoproliferative disorders.

@en

Epidemiology of invasive fungal disease in lymphoproliferative disorders.

@nl

type

Item

label

Epidemiology of invasive fungal disease in lymphoproliferative disorders.

@en

Epidemiology of invasive fungal disease in lymphoproliferative disorders.

@nl

prefLabel

Epidemiology of invasive fungal disease in lymphoproliferative disorders.

@en

Epidemiology of invasive fungal disease in lymphoproliferative disorders.

@nl

P1476

Epidemiology of invasive fungal disease in lymphoproliferative disorders.

@en

P2093

Jasmine C Teng

http://www.w3.org/2001/XMLSchema#string

John F Seymour

http://www.w3.org/2001/XMLSchema#string

Michelle R Ananda-Rajah

http://www.w3.org/2001/XMLSchema#string

Senthil M Lingaratnam

http://www.w3.org/2001/XMLSchema#string

P2860

Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study.

Attributable hospital cost and antifungal treatment of invasive fungal diseases in high-risk hematology patients: an economic modeling approach

Adverse interactions between antifungal azoles and vincristine: review and analysis of cases.

Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab*.

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial.

Introduction to the updated Australian and New Zealand consensus guidelines for the use of antifungal agents in the haematology/oncology setting, 2014.

Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.

Invasive fungal infections in patients with multiple myeloma: a multi-center study in the era of novel myeloma therapies.

Incidence and outcomes of invasive fungal disease in adult patients with acute lymphoblastic leukemia treated with hyperfractionated cyclophosphamide, vincristine, doxorubicin and dexamethasone: implications for prophylaxis.

P304

e462-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2015.126698

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-07-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280389163

http://www.w3.org/2001/XMLSchema#string

P698

26206797

http://www.w3.org/2001/XMLSchema#string

P932

4825301

http://www.w3.org/2001/XMLSchema#string